FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

396411005: Toxoid (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1764328019 Toxoid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1776349017 Toxoid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3265061000005116 toxoid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    toxoid Is a Drug, medicament or biological substance false Inferred relationship Some
    toxoid Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some
    toxoid Is a vaccine false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    tetanustoxoid Is a False toxoid Inferred relationship Some
    Diphtheria toxoid Is a False toxoid Inferred relationship Some
    Clostridium haemolyticum-, Clostridium novyi- og Clostridium perfringens type C & D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi-, Clostridium sordellii-, Clostridium perfringens type C & D- og Moraxella bovis-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C-antitoxin og Escherichia coli-antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type D-antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-, Clostridium perfringens type C-, Erysipelothrix rhusiopathiae-, Escherichia coli- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C & D-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Pasteurella haemolytica-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-, Erysipelothrix rhusiopathiae- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi- og Clostridium sordellii-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Borrelia burgdorferi-bakterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Salmonella Typhimurium-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    overførbar gastroenterit-immunitetsinducer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    C & D-bakterin/toksoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    mykobakteriel cellevægsimmunstimulator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    overførbar gastroenteritisvaccine - clostridium perfringens type C - escherichia coli bakterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C & D-tetanustoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C-antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Staphylococcus aureus-faglysat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    loppeantigen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium haemolyticum- og Clostridium novyi-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    antitoxin mod dyresygdomme The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C & D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi-, Clostridium sordellii-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi-, Clostridium sordellii- og Clostridium perfringens type C & D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium sordellii- og Clostridium perfringens-type-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Toxoid (animal) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi-, Clostridium sordellii-, Clostridium perfringens type C & D- og Hemophilus somnus-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium novyi-, Clostridium sordellii- og Haemophilus somnus-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    toxin, dyr The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-, Escherichia coli- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Chlostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii- og Leptospira pomona-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium tetani- og Clostridium perfringens type C & D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    mykobakteriel cellevægsfraktionsimmunstimulator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii-, Clostridium perfringens type C & D-, Leptospira pomona-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium haemolyticum-, clostridium novyi- og Clostridium sordellii-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Staphylococcus aureus-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium botulinum type C-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C & D- og Escherichia coli-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Pasteurella multocida-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C-, Erysipelothrix rhusiopathiae- og Escherichia coli-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum- og Clostridium sordellii-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Erysipelothrix rhusiopathiae- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium botulinum type B-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    autogent bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Aeromonas salmonicida-bakterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum- og Clostridium novyi-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin, toksoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Chlostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-, Erysipelothrix rhusiopathiae-, Haemophilus parasuis- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C & D-antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium sordellii-, Pasteurella haemolytica- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-, Clostridium perfringens type C- og Escherichia coli-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Propionibacterium acnes-immunstimulator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium chauvoei-, Clostridium septicum-, Clostridium haemolyticum-, Clostridium novyi-, Clostridium sordellii- og Clostridium perfringens type C & D-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium novyi-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type C- og Escherichia coli-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Clostridium perfringens type D-toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica- , Clostridium perfringens type C-, Escherichia coli- og Pasteurella multocida-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Escherichia coli-bakterintoxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Botulinum toxoid (substance) Is a False toxoid Inferred relationship Some
    Heptavalent hesteantitoksin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    trivalent hesteantitoksin mod botulisme The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    difterivaccine Is a False toxoid Inferred relationship Some
    bakterin indeholdende parvovirus - pseudorabiesvaccine - erysipelothrix rhusiopathiae - leptospira bratislava - canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bovine rhinotracheitis - parainfluenza 3 vaccine - haemophilus somnus bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirusvaccine - erysipelothrix rhusiopathiae - leptospira bratislava canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Corynebacterium pyogenes-, Pasteurella haemolytica-, multocida-antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bordetella bronchiseptica-vaccine, Erysipelothrix rhusiopathiae- og Pasteurella multocida-bakterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirusvaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - pasteurella multocida The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirus - pseudorabiesvaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirusvaccine - leptospira The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - pasteurella haemolytica bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirusvaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Corynebacterium pyogenes-, Escherichia coli-, Pasteurella multocida- og Salmonella Typhimurium-antitoxin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    overførbar gastroenteritisvaccine - clostridium perfringens type C bakterin - toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    bakterin indeholdende parvovirus - pseudorabiesvaccine - erysipelothrix rhusiopathiae - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Corynebacterium pyogenes - Pasteurella multocida-antiserum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    Bovine virus diarrhea vaccine/leptospira canicola/grippotyphosa/hardjo/icterohemorrhagiae/pomona bacterin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some
    toxoid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some 1
    Pentavalent botulinum toxoid vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False toxoid Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start